Home › Funds › Pacific Capital Partners Ltd › WST

Pacific Capital Partners Ltd position in WST

WEST PHARMACEUTICAL SVSC INC · Health Care

Pacific Capital Partners Ltd reported holding 2,527 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q3 2026 13F filing — a position valued at US$937K, representing 0.71% of its reported portfolio and ranking #36 among its reported holdings. Pacific Capital Partners Ltd has disclosed WST holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)2.53K sh
Reported value held$936.91K
Portfolio Weight0.71%
First reportedQ2 2026
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Pacific Capital Partners Ltd's WST position evolved

Pacific Capital Partners Ltd first disclosed a stake in WST in Q2 2026 at 3,700 shares (US$1.3M). Across 2 filings, Pacific Capital Partners Ltd increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,527 shares valued at US$937K — a reduction of -1,173 shares quarter over quarter.. Notable position changes include a 32% trim in Q3 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 3.70K $1.33M New
Q3 2026 2.53K $936.91K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WST and 13F data

WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 28 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$744.4M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WST

All WST fund holders →

FAQ

How long has Pacific Capital Partners Ltd held WST?

Pacific Capital Partners Ltd has disclosed WST holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Pacific Capital Partners Ltd's current position in WST?

As of Q3 2026, Pacific Capital Partners Ltd holds 2.53K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $936.91K, representing 0.71% of its reported portfolio and ranking #36.

Has Pacific Capital Partners Ltd been buying or selling WST?

In the latest 13F filing (Q3 2026), Pacific Capital Partners Ltd reduced its position in WST.

Which other funds hold WST?

Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.